查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1519478

2024-2032 年按产品、技术、动物类型、疾病类型、最终用户和地区分類的兽医分子诊断市场报告

Veterinary Molecular Diagnostics Market Report by Product, Technology, Animal Type, Disease Type, End User, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 136 Pages | 商品交期: 2-3个工作天内

价格

IMARC Group年，全球兽医分子诊断市场规模达6.908亿美元。大众越来越多地接受宠物，分子诊断技术不断进步，以及越来越多地实施严格的监管指南和品质控制标准以标准化兽医实践中的分子诊断测试，是推动兽医分子诊断市场成长的一些主要因素。

兽医分子诊断市场分析：

主要市场驱动因素：宠物拥有量的增加是推动市场成长的重要因素之一。此外，对能够快速准确地检测动物传染源、有助于防止疾病传播给人类并保障公众健康的分子诊断的需求不断增长，正在推动市场的成长。

主要市场趋势：在兽医护理中越来越多地使用个人化医疗来客製化治疗计划和预测疾病易感性，这为整个市场创造了积极的前景。

竞争格局：一些领先的兽医分子诊断公司包括 Biochek BV、bioMerieux SA、HealthGene Corporation、Heska Corporation、IDEXX Laboratories Inc.、INDICAL BIOSCIENCE GmbH、Ingenetix GmbH、NEOGEN Corporation、Qiagen NV、Thermo Fisher Scientific Inc.、Veteriary Molectix Inc. 和Zoetis Inc. 等。

地理趋势：根据报告，北美占据最大的市场份额。这可以归因于大众越来越多地收养宠物来享受陪伴。除此之外，分子诊断测试的价格不断提高，使其成为更广泛的兽医实践的可行选择，也促进了市场的成长。

挑战与机会：兽医分子诊断的挑战包括需要具有成本效益和使用者友好的技术，以及需要广泛的验证以确保不同动物物种的准确性。机会在于开发快速、即时诊断的检测方法以及基于遗传资讯的个人化治疗计划的潜力，从而推进动物保健。

兽医分子诊断市场趋势：

大众越来越多地收养宠物

大众越来越接受宠物，对兽医分子诊断市场产生了积极影响。宠物拥有量的激增导致对包括诊断在内的兽医服务的需求增加。例如，根据宠物食品製造商协会2021年3月公布的宠物数量资料，英国超过59%的家庭养有宠物，2021年宠物数量将超过3260万隻。反过来又增加了兽医分子诊断市场的需求。此外，狗和猫是宠物父母收养的热门宠物。例如，到 2022 年，狗的数量约为 6.045 亿隻，而猫的数量约为 6.045 亿隻。全球 4.082 亿。除此之外，美国宠物产品协会在2022年4月发布的数据显示，2021年美国宠物产业总支出达到1,236亿美元，高于2020年的1,036亿美元。的成长。

动物疾病盛行率上升

动物疾病盛行率的上升推动了兽医分子诊断市场的成长。根据卡加利大学2021 年6 月发表的一项研究，该研究旨在调查家犬中多房棘球绦虫的感染情况，以推断其在人畜共患病传播中的潜在作用，该研究指出，多房棘球绦虫是北半球的一种寄生蠕虫（加拿大艾伯塔省） ），通常在最终宿主和中间宿主之间循环。但在城市地区，家养的狗也可能成为这种寄生虫的宿主，由于它们距离很近，这可能成为人类的重大风险因素。除此之外，据估计，每年有五分之一的农场动物因疾病而死亡，还有更多的动物受到疾病的影响。根据新兴病原体研究所2021年11月发表的文章，牛隻呼吸道疾病占饲养场疾病的75%，每年造成养牛者的经济损失超过10亿美元。据估计，红眼症每年造成的损失为 1.5 亿美元，每隻动物因腐蹄病对乳製品生产商造成的损失为 120 美元至 350 美元。动物中这种不断增加的损失和遗传性疾病预计将推动对兽医分子诊断的需求，从而扩大兽医分子诊断的市场份额。

分子诊断技术不断进步

分子诊断技术的不断进步正在推动市场的成长。聚合酶炼式反应 (PCR)、新一代定序 (NGS) 和微阵列分析等尖端分子诊断技术不断发展，为兽医提供有关动物健康的无与伦比的见解。此外，各个主要市场参与者正在推出改进的诊断套件和仪器，以促进高品质的诊断和治疗。例如，2022 年 4 月，格林斯博罗的 Carolina Liquid Chemistries Corp 签署了一项半独家协议，为美国兽医市场分销便携式分析仪。该公司经销 SeamatySMT-120 VP 兽医自动化化学分析仪，这是一款紧凑型全自动化学、电解质免疫分析和凝血分析仪，用于动物健康诊断。同样，2021 年 9 月，Micro Vet Diagnostics 推出了 Micro-chem II，这是一款用于动物健康的全新化学、电解质、免疫测定和凝血分析仪，可产生准确的参考和实验室品质的结果。此类创新正在提高兽医实验室的效率，并缩短测试结果的周转时间，预计这将在未来几年推动兽医分子诊断市场的收入。

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 资料来源
    • 主要资源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球兽医分子诊断市场

  • 市场概况
  • 市场业绩
  • COVID-19 的影响
  • 市场预测

第 6 章：市场区隔：依产品

  • 试剂盒和试剂
    • 市场走向
    • 市场预测
  • 仪器
    • 市场走向
    • 市场预测
  • 软体和服务
    • 市场走向
    • 市场预测

第 7 章：市场区隔：依技术

  • 实时萤光定量PCR
    • 市场走向
    • 市场预测
  • 微阵列
    • 市场走向
    • 市场预测
  • DNA定序
    • 市场走向
    • 市场预测

第 8 章：市场区隔：依动物类型

  • 伴侣动物
    • 市场走向
    • 市场预测
  • 畜牧动物
    • 市场走向
    • 市场预测

第 9 章：市场区隔：依疾病类型

  • 媒介传播疾病
    • 市场走向
    • 市场预测
  • 呼吸道病原体
    • 市场走向
    • 市场预测
  • 腹泻病原体
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 10 章：市场区隔：依最终用户

  • 兽医院
    • 市场走向
    • 市场预测
  • 临床实验室
    • 市场走向
    • 市场预测
  • 研究机构
    • 市场走向
    • 市场预测

第 11 章：市场区隔：按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 市场走向
    • 市场细分：按国家/地区
    • 市场预测

第 12 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 13 章：价值链分析

第 14 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 15 章：价格分析

第16章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Biochek BV
    • bioMerieux SA
    • HealthGene Corporation
    • Heska Corporation
    • IDEXX Laboratories Inc.
    • INDICAL BIOSCIENCE GmbH
    • Ingenetix GmbH
    • NEOGEN Corporation
    • Qiagen NV
    • Thermo Fisher Scientific Inc.
    • Veterinary Molecular Diagnostics Inc.
    • Zoetis Inc.
Product Code: SR112024A5121

The global veterinary molecular diagnostics market size reached US$ 690.8 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 1,391.9 Million by 2032, exhibiting a growth rate (CAGR) of 7.9% during 2024-2032. The growing adoption of pets among the masses, increasing advancements in molecular diagnostic technologies, and rising implementation of stringent regulatory guidelines and quality control standards to standardize molecular diagnostic tests in veterinary practice are some of the major factors propelling the veterinary molecular diagnostics market growth.

Veterinary Molecular Diagnostics Market Analysis:

Major Market Drivers: Increasing pet ownership is one of the significant factors driving the growth of the market. Additionally, the rising demand for molecular diagnostics that can rapidly and accurately detect infectious agents in animals, helping to prevent disease transmission to humans and safeguard public health, is impelling the growth of the market.

Key Market Trends: The rising utilization of personalized medicine in veterinary care to tailor treatment plans and predict disease susceptibility is creating a positive outlook for the overall market.

Competitive Landscape: Some of the leading veterinary molecular diagnostics companies include Biochek B.V., bioMerieux SA, HealthGene Corporation, Heska Corporation, IDEXX Laboratories Inc., INDICAL BIOSCIENCE GmbH, Ingenetix GmbH, NEOGEN Corporation, Qiagen N.V, Thermo Fisher Scientific Inc., Veterinary Molecular Diagnostics Inc., and Zoetis Inc., among others.

Geographical Trends: According to the report, North America accounted for the largest market share. This can be attributed to the rising adoption of pets among the masses to enjoy their companionship. Besides this, the increasing affordability of molecular diagnostic tests, making them a viable option for a wider range of veterinary practices, is contributing to the growth of the market.

Challenges and Opportunities: Challenges in veterinary molecular diagnostics include the need for cost-effective and user-friendly technologies, as well as the requirement for extensive validation to ensure accuracy across diverse animal species. Opportunities lie in the development of rapid, point-of-care assays for timely diagnosis and the potential for personalized treatment plans based on genetic information, advancing animal health care.

Veterinary Molecular Diagnostics Market Trends:

Growing Adoption of Pets Among the Masses

The growing adoption of pets among the masses is positively influencing the veterinary molecular diagnostics market. This surge in pet ownership is resulting in a higher demand for veterinary services, including diagnostics. For instance, according to the pet population data published in March 2021 by the Pet Food Manufacturers Association, over 59% of households in the United Kingdom had pets, with over 32.6 million pets in 2021. The trend of treating pets as family members is growing, which in turn is augmenting the veterinary molecular diagnostics market demand. Moreover, dogs and cats are the popular pets adopted by pet parents. For instance, the dog population was around 604.5 million in 2022, whereas the cat population was approx. 408.2 million globally. Besides this, the American Pet Products Association published in April 2022 that the total American pet industry expenditure reached US$ 123.6 Billion in 2021, up from US$ 103.6 Billion in 2020. The rise in animal health expenditure is expected to drive the growth of the veterinary molecular diagnostics market, as a significant portion of pet owners are expected to use advanced diagnostic modalities for various disease conditions in animals and propel the veterinary molecular diagnostics market's recent price.

Rising Prevalence of Animal Diseases

The rising prevalence of animal diseases is bolstering the growth of the veterinary molecular diagnostics market. According to a study published by the University of Calgary in June 2021, conducted to investigate the infections of Echinococcus multilocularis in domestic dogs to infer their potential role in zoonotic transmission, stated that Echinococcus multilocularis, a parasitic helminth of the northern hemisphere (Alberta, Canada), normally cycles through definitive and intermediate hosts. But in urban areas, domestic dogs can also become hosts for this parasite, which could become a significant risk factor to humans due to their proximity. Besides this, it is estimated that one in five farm animals is lost due to diseases each year, while many more animals suffer the effects of illness. According to an article published by Emerging Pathogen Institutes in November 2021, bovine respiratory diseases account for 75% of feedlot illnesses, and economic losses to cattle producers exceed US$ 1 Billion every year. The estimated costs for pinkeye are US$ 150 Million yearly, and losses to dairy producers due to foot rot range from US$ 120 to US$ 350 per animal. Such increasing losses and genetic disorders among animals are expected to drive the demand for veterinary molecular diagnostics, thereby augmenting the veterinary molecular diagnostics market share.

Increasing Advancements in Molecular Diagnostic Technologies

The increasing advancements in molecular diagnostic technologies are bolstering the growth of the market. Cutting-edge molecular diagnostic technologies, such as polymerase chain reaction (PCR), next-generation sequencing (NGS), and microarray analysis, are continually evolving to provide veterinarians with unparalleled insights into the health of animals. Moreover, various key market players are launching improved diagnostics kits and instruments to facilitate quality diagnosis and treatments. For instance, in April 2022, Carolina Liquid Chemistries Corp of Greensboro signed a semi-exclusive agreement to distribute a portable analyzer for the US veterinary market. The company distributed the SeamatySMT-120 VP veterinary automated chemistry analyzer, a compact, fully automatic chemistry, electrolyte immunoassay, and coagulation analyzer for animal health diagnosis. Similarly, in September 2021, Micro Vet Diagnostics launched Micro-chem II, a completely new chemistry, electrolyte, immunoassay, and coagulation analyzer for animal health, producing accurate reference and laboratory-quality results. Such innovations are enhancing the efficiency of veterinary laboratories and enabling quicker turnaround times for test results, which is anticipated to propel veterinary molecular diagnostics market revenue in the coming years.

Global Veterinary Molecular Diagnostics Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the global, regional, and country levels from 2024-2032. Our report has categorized the market based on product, technology, animal type, disease type, and end user.

Breakup by Product:

Kits and Reagents

Instruments

Software and Services

Kits and reagents dominate the market

The veterinary molecular diagnostics market report has provided a detailed breakup and analysis of the market based on the product. This includes kits and reagents, instruments, and software and services. According to the report, kits and reagents represented the largest segment.

In veterinary molecular diagnostics, various kits and reagents are required to conduct tests and experiments to detect and analyze nucleic acids from animal samples. These molecular diagnostic tools are used for a wide range of purposes, including disease detection, genotyping, pathogen identification, and genetic research in animals. Kits and reagents for next-generation sequencing (NGS) are employed to characterize the genomes of pathogens, aiding in the study of their evolution, drug resistance, and virulence factors. They also enable the study of epigenetic modifications in animal DNA, providing insights into gene regulation and potential links between epigenetic changes and disease susceptibility.

Breakup by Technology:

Real Time PCR

Microarray

DNA Sequencing

Real time PCR holds the largest share in the market

A detailed breakup and analysis of the market based on the technology has also been provided in the report. This includes real time PCR, microarray, and DNA sequencing. According to the report, real time PCR accounted for the largest market share.

Real-time PCR (Polymerase Chain Reaction) in Veterinary Molecular Diagnostics is a molecular biology technique used to amplify and quantify DNA in real-time during the PCR process. It is a sensitive and accurate method for measuring the amount of a target DNA or RNA molecule in a biological sample. Real-time PCR is widely employed to examine and quantify pathogens in animals, including viruses, bacteria, fungi, and parasites. It also allows for early and accurate diagnosis, enabling prompt treatment and disease management.

Breakup by Animal Type:

Companion Animal

Livestock Animal

Companion animal holds the biggest share in the market

A detailed breakup and analysis of the market based on the animal type have also been provided in the report. This includes companion animal and livestock animal. According to the report, companion animal accounted for the largest market share.

As per the veterinary molecular diagnostics market statistics by IMARC, the increasing trend of pet humanization is contributing to the growth of this segment. Companion animals, like dogs, cats, and other pets, require veterinary molecular diagnostics to detect diseases and health conditions. Some companion animals are prone to genetic disorders or inherited diseases. The rising pet ownership and growing consciousness of pet parents regarding the health of their pets are bolstering the market for molecular diagnostics. For instance, there are over 31 million pet dogs and around 2.44 million pet cats in India. The pet cat population may reach 4.89 million by 2026. 11% of people in India own at least four pets. Molecular diagnostics can identify genetic mutations or markers associated with these conditions, allowing breeders to make informed decisions about breeding and helping veterinarians manage the health of affected animals. Molecular tests can rapidly identify the presence of infectious agents, including viruses, bacteria, and parasites. This is crucial for diagnosing and managing diseases like parvovirus, feline leukemia, and Lyme disease.

Breakup by Disease Type:

Vector-borne Diseases

Respiratory Pathogens

Diarrhea Pathogens

Others

Vector-borne diseases hold the maximum share in the market

A detailed breakup and analysis of the market based on the disease type have also been provided in the report. This includes vector-borne diseases, respiratory pathogens, diarrhea pathogens, and others. According to the report, vector-borne diseases accounted for the largest market share.

Vector-borne diseases in animals are infections that are transmitted from one animal to another through the bites of arthropod vectors, similar to how these diseases are transmitted to humans. They can have significant economic impacts on agriculture and can reduce the productivity of livestock, decrease meat and milk production, and even lead to animal deaths. Molecular diagnostic methods, like PCR, swiftly and precisely identify the genetic material of pathogens causing vector-borne diseases in animals, crucial for efficient disease control. Such techniques aid in tracking disease advancement in infected animals, enabling veterinarians to gauge infection severity and adapt treatment strategies accordingly.

Breakup by End User:

Veterinary Hospitals

Clinical Laboratories

Research Institutes

A detailed breakup and analysis of the market based on the end user have also been provided in the report. This includes veterinary hospitals, clinical laboratories, and research institutes.

The veterinary molecular diagnostics market overview indicates that veterinary molecular diagnostics plays a crucial role in veterinary hospitals by offering advanced tools and techniques for the monitoring and treatment of diseases in animals. They can be used in biosecurity protocols to quickly identify and isolate infected animals, preventing the spread of contagious diseases within veterinary hospitals and breeding facilities.

Veterinary molecular diagnostics plays a pivotal role in clinical laboratories dedicated to animal healthcare. These sophisticated techniques harness the power of molecular biology to provide rapid, precise, and comprehensive insights into the health of animals. Besides this, in research institutes focused on enhancing understanding of animal health, genetics, and disease mechanisms, veterinary molecular diagnostics is essential. Utilizing state-of-the-art molecular methods like Polymerase Chain Reaction (PCR), DNA sequencing, and genotyping, these institutes conduct diverse studies benefiting both animal and human welfare.

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America exhibits a clear dominance, accounting for the largest veterinary molecular diagnostics market share

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

North America held the biggest market share due to the rising adoption of pets among the masses to enjoy their companionship. For instance, according to pet ownership statistics by Forbes, pet ownership in the U.S. jumped significantly over the past three decades. As of 2024, 66% of U.S. households (86.9 million homes) own a pet. That is up from 56% in 1988. Moreover, the rise in the prevalence of animal diseases and injuries is also a major factor bolstering the market growth. According to the 2021-2022 National Pet Owners Survey conducted by the American Pet Products Association (APPA), the annual expenditure on a routine visit for dogs accounts for US$ 242 and US$ 178 for cats in the country. Furthermore, the increasing affordability of molecular diagnostic tests, making them a viable option for a wider range of veterinary practices, is contributing to the growth of the market. Apart from this, the escalating number of product launches in North America that focus on molecular diagnostics for animals drives the market growth. For instance, in January 2022, IDEXX Laboratories, Inc. expanded its reference laboratory menu of tests and services that will enable veterinarians to better meet the challenges of diagnosing and treating cancer. Such activities are expected to positively impact the veterinary molecular diagnostics market outlook in the coming years.

Competitive Landscape:

Key market players are developing innovative and more accurate diagnostic tests for animals by creating new assays, improving the sensitivity and specificity of existing tests, and expanding their test menu to cover a broader range of diseases. They are also expanding their product portfolios to include a wider range of diagnostic tests for different animal species, including companion animals (dogs and cats), livestock (cattle, pigs, and poultry), and exotic animals. Top companies are establishing partnerships or collaborations with distributors and veterinary clinics in different regions to reach a global customer base. They are also incorporating automation and advanced technologies into their diagnostic platforms to streamline testing processes, reduce turnaround times, and enhance the accuracy of results.

The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

Biochek B.V.

bioMerieux SA

HealthGene Corporation

Heska Corporation

IDEXX Laboratories Inc.

INDICAL BIOSCIENCE GmbH

Ingenetix GmbH

NEOGEN Corporation

Qiagen N.V

Thermo Fisher Scientific Inc.

Veterinary Molecular Diagnostics Inc.

Zoetis Inc.

(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)

Veterinary Molecular Diagnostics Market Recent Developments:

May 2024: A molecular diagnostics startup, Fuse Diagnostics, announced the successful completion of an oversubscribed seed investment round in which it raised a total of 1.6 million pounds (US$ 2 Million) from a group of angel investors and the agency Innovate UK. Fuse is focused on the development of its Apex range, aimed at clinical diagnostics and veterinary applications.

February 2024: MiDOG Animal Diagnostics LLC, a prominent leader in microbiome-based veterinary diagnostic solutions employing Next Generation DNA Sequencing analysis, unveiled a revamped branding strategy in 2024. By extending its diagnostic capabilities to encompass a diverse range of animal species, MiDOG aims to equip veterinarians with the tools needed to address acute, chronic, and non-responsive infections effectively.

November 2023: Antech, the full-service veterinary diagnostics business that is part of the Science & Diagnostics division of Mars Petcare, announced the opening of a new UK veterinary diagnostics laboratory in Warwick. This expands Antech's UK lab network, which also includes Southfields Veterinary Specialists Diagnostic Laboratory and the Dick White Referrals Diagnostic Laboratory.

Key Questions Answered in This Report

  • 1. What was the size of the global veterinary molecular diagnostics market in 2023?
  • 2. What is the expected growth rate of the global veterinary molecular diagnostics market during 2024-2032?
  • 3. What are the key factors driving the global veterinary molecular diagnostics market?
  • 4. What has been the impact of COVID-19 on the global veterinary molecular diagnostics market?
  • 5. What is the breakup of the global veterinary molecular diagnostics market based on the product?
  • 6. What is the breakup of the global veterinary molecular diagnostics market based on the technology?
  • 7. What is the breakup of the global veterinary molecular diagnostics market based on the animal type?
  • 8. What is the breakup of the global veterinary molecular diagnostics market based on the disease type?
  • 9. What are the key regions in the global veterinary molecular diagnostics market?
  • 10. Who are the key players/companies in the global veterinary molecular diagnostics market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Veterinary Molecular Diagnostics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Kits and Reagents
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Instruments
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Software and Services
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Technology

  • 7.1 Real Time PCR
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Microarray
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 DNA Sequencing
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Animal Type

  • 8.1 Companion Animal
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Livestock Animal
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by Disease Type

  • 9.1 Vector-borne Diseases
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Respiratory Pathogens
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Diarrhea Pathogens
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Others
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast

10 Market Breakup by End User

  • 10.1 Veterinary Hospitals
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 Clinical Laboratories
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast
  • 10.3 Research Institutes
    • 10.3.1 Market Trends
    • 10.3.2 Market Forecast

11 Market Breakup by Region

  • 11.1 North America
    • 11.1.1 United States
      • 11.1.1.1 Market Trends
      • 11.1.1.2 Market Forecast
    • 11.1.2 Canada
      • 11.1.2.1 Market Trends
      • 11.1.2.2 Market Forecast
  • 11.2 Asia-Pacific
    • 11.2.1 China
      • 11.2.1.1 Market Trends
      • 11.2.1.2 Market Forecast
    • 11.2.2 Japan
      • 11.2.2.1 Market Trends
      • 11.2.2.2 Market Forecast
    • 11.2.3 India
      • 11.2.3.1 Market Trends
      • 11.2.3.2 Market Forecast
    • 11.2.4 South Korea
      • 11.2.4.1 Market Trends
      • 11.2.4.2 Market Forecast
    • 11.2.5 Australia
      • 11.2.5.1 Market Trends
      • 11.2.5.2 Market Forecast
    • 11.2.6 Indonesia
      • 11.2.6.1 Market Trends
      • 11.2.6.2 Market Forecast
    • 11.2.7 Others
      • 11.2.7.1 Market Trends
      • 11.2.7.2 Market Forecast
  • 11.3 Europe
    • 11.3.1 Germany
      • 11.3.1.1 Market Trends
      • 11.3.1.2 Market Forecast
    • 11.3.2 France
      • 11.3.2.1 Market Trends
      • 11.3.2.2 Market Forecast
    • 11.3.3 United Kingdom
      • 11.3.3.1 Market Trends
      • 11.3.3.2 Market Forecast
    • 11.3.4 Italy
      • 11.3.4.1 Market Trends
      • 11.3.4.2 Market Forecast
    • 11.3.5 Spain
      • 11.3.5.1 Market Trends
      • 11.3.5.2 Market Forecast
    • 11.3.6 Russia
      • 11.3.6.1 Market Trends
      • 11.3.6.2 Market Forecast
    • 11.3.7 Others
      • 11.3.7.1 Market Trends
      • 11.3.7.2 Market Forecast
  • 11.4 Latin America
    • 11.4.1 Brazil
      • 11.4.1.1 Market Trends
      • 11.4.1.2 Market Forecast
    • 11.4.2 Mexico
      • 11.4.2.1 Market Trends
      • 11.4.2.2 Market Forecast
    • 11.4.3 Others
      • 11.4.3.1 Market Trends
      • 11.4.3.2 Market Forecast
  • 11.5 Middle East and Africa
    • 11.5.1 Market Trends
    • 11.5.2 Market Breakup by Country
    • 11.5.3 Market Forecast

12 SWOT Analysis

  • 12.1 Overview
  • 12.2 Strengths
  • 12.3 Weaknesses
  • 12.4 Opportunities
  • 12.5 Threats

13 Value Chain Analysis

14 Porters Five Forces Analysis

  • 14.1 Overview
  • 14.2 Bargaining Power of Buyers
  • 14.3 Bargaining Power of Suppliers
  • 14.4 Degree of Competition
  • 14.5 Threat of New Entrants
  • 14.6 Threat of Substitutes

15 Price Analysis

16 Competitive Landscape

  • 16.1 Market Structure
  • 16.2 Key Players
  • 16.3 Profiles of Key Players
    • 16.3.1 Biochek B.V.
      • 16.3.1.1 Company Overview
      • 16.3.1.2 Product Portfolio
    • 16.3.2 bioMerieux SA
      • 16.3.2.1 Company Overview
      • 16.3.2.2 Product Portfolio
      • 16.3.2.3 Financials
      • 16.3.2.4 SWOT Analysis
    • 16.3.3 HealthGene Corporation
      • 16.3.3.1 Company Overview
      • 16.3.3.2 Product Portfolio
    • 16.3.4 Heska Corporation
      • 16.3.4.1 Company Overview
      • 16.3.4.2 Product Portfolio
      • 16.3.4.3 Financials
      • 16.3.4.4 SWOT Analysis
    • 16.3.5 IDEXX Laboratories Inc.
      • 16.3.5.1 Company Overview
      • 16.3.5.2 Product Portfolio
      • 16.3.5.3 Financials
      • 16.3.5.4 SWOT Analysis
    • 16.3.6 INDICAL BIOSCIENCE GmbH
      • 16.3.6.1 Company Overview
      • 16.3.6.2 Product Portfolio
    • 16.3.7 Ingenetix GmbH
      • 16.3.7.1 Company Overview
      • 16.3.7.2 Product Portfolio
    • 16.3.8 NEOGEN Corporation
      • 16.3.8.1 Company Overview
      • 16.3.8.2 Product Portfolio
      • 16.3.8.3 Financials
      • 16.3.8.4 SWOT Analysis
    • 16.3.9 Qiagen N.V
      • 16.3.9.1 Company Overview
      • 16.3.9.2 Product Portfolio
      • 16.3.9.3 Financials
      • 16.3.9.4 SWOT Analysis
    • 16.3.10 Thermo Fisher Scientific Inc.
      • 16.3.10.1 Company Overview
      • 16.3.10.2 Product Portfolio
      • 16.3.10.3 Financials
      • 16.3.10.4 SWOT Analysis
    • 16.3.11 Veterinary Molecular Diagnostics Inc.
      • 16.3.11.1 Company Overview
      • 16.3.11.2 Product Portfolio
    • 16.3.12 Zoetis Inc.
      • 16.3.12.1 Company Overview
      • 16.3.12.2 Product Portfolio
      • 16.3.12.3 Financials
      • 16.3.12.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Veterinary Molecular Diagnostics Market: Major Drivers and Challenges
  • Figure 2: Global: Veterinary Molecular Diagnostics Market: Sales Value (in Million US$), 2018-2023
  • Figure 3: Global: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 4: Global: Veterinary Molecular Diagnostics Market: Breakup by Product (in %), 2023
  • Figure 5: Global: Veterinary Molecular Diagnostics Market: Breakup by Technology (in %), 2023
  • Figure 6: Global: Veterinary Molecular Diagnostics Market: Breakup by Animal Type (in %), 2023
  • Figure 7: Global: Veterinary Molecular Diagnostics Market: Breakup by Disease Type (in %), 2023
  • Figure 8: Global: Veterinary Molecular Diagnostics Market: Breakup by End User (in %), 2023
  • Figure 9: Global: Veterinary Molecular Diagnostics Market: Breakup by Region (in %), 2023
  • Figure 10: Global: Veterinary Molecular Diagnostics (Kits and Reagents) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Veterinary Molecular Diagnostics (Kits and Reagents) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Veterinary Molecular Diagnostics (Instruments) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Veterinary Molecular Diagnostics (Instruments) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Veterinary Molecular Diagnostics (Software and Services) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Veterinary Molecular Diagnostics (Software and Services) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Veterinary Molecular Diagnostics (Real Time PCR) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Veterinary Molecular Diagnostics (Real Time PCR) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Veterinary Molecular Diagnostics (Microarray) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Veterinary Molecular Diagnostics (Microarray) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Veterinary Molecular Diagnostics (DNA Sequencing) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Veterinary Molecular Diagnostics (DNA Sequencing) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Veterinary Molecular Diagnostics (Companion Animal) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Veterinary Molecular Diagnostics (Companion Animal) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Veterinary Molecular Diagnostics (Livestock Animal) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Veterinary Molecular Diagnostics (Livestock Animal) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: Veterinary Molecular Diagnostics (Vector-borne Diseases) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: Veterinary Molecular Diagnostics (Vector-borne Diseases) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Global: Veterinary Molecular Diagnostics (Respiratory Pathogens) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Global: Veterinary Molecular Diagnostics (Respiratory Pathogens) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: Global: Veterinary Molecular Diagnostics (Diarrhea Pathogens) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: Global: Veterinary Molecular Diagnostics (Diarrhea Pathogens) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: Global: Veterinary Molecular Diagnostics (Other Disease Types) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: Global: Veterinary Molecular Diagnostics (Other Disease Types) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: Global: Veterinary Molecular Diagnostics (Veterinary Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: Global: Veterinary Molecular Diagnostics (Veterinary Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: Global: Veterinary Molecular Diagnostics (Clinical Laboratories) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: Global: Veterinary Molecular Diagnostics (Clinical Laboratories) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: Global: Veterinary Molecular Diagnostics (Research Institutes) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: Global: Veterinary Molecular Diagnostics (Research Institutes) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: North America: Veterinary Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: North America: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: United States: Veterinary Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: United States: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: Canada: Veterinary Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: Canada: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: Asia-Pacific: Veterinary Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: Asia-Pacific: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: China: Veterinary Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: China: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: Japan: Veterinary Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: Japan: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: India: Veterinary Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: India: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: South Korea: Veterinary Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: South Korea: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: Australia: Veterinary Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: Australia: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: Indonesia: Veterinary Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: Indonesia: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: Others: Veterinary Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: Others: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: Europe: Veterinary Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: Europe: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Germany: Veterinary Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Germany: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: France: Veterinary Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: France: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: United Kingdom: Veterinary Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: United Kingdom: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Italy: Veterinary Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Italy: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Spain: Veterinary Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Spain: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: Russia: Veterinary Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 75: Russia: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 76: Others: Veterinary Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 77: Others: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 78: Latin America: Veterinary Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 79: Latin America: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 80: Brazil: Veterinary Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 81: Brazil: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 82: Mexico: Veterinary Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 83: Mexico: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 84: Others: Veterinary Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 85: Others: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 86: Middle East and Africa: Veterinary Molecular Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 87: Middle East and Africa: Veterinary Molecular Diagnostics Market: Breakup by Country (in %), 2023
  • Figure 88: Middle East and Africa: Veterinary Molecular Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 89: Global: Veterinary Molecular Diagnostics Industry: SWOT Analysis
  • Figure 90: Global: Veterinary Molecular Diagnostics Industry: Value Chain Analysis
  • Figure 91: Global: Veterinary Molecular Diagnostics Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Veterinary Molecular Diagnostics Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Veterinary Molecular Diagnostics Market Forecast: Breakup by Product (in Million US$), 2024-2032
  • Table 3: Global: Veterinary Molecular Diagnostics Market Forecast: Breakup by Technology (in Million US$), 2024-2032
  • Table 4: Global: Veterinary Molecular Diagnostics Market Forecast: Breakup by Animal Type (in Million US$), 2024-2032
  • Table 5: Global: Veterinary Molecular Diagnostics Market Forecast: Breakup by Disease Type (in Million US$), 2024-2032
  • Table 6: Global: Veterinary Molecular Diagnostics Market Forecast: Breakup by End User (in Million US$), 2024-2032
  • Table 7: Global: Veterinary Molecular Diagnostics Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 8: Global: Veterinary Molecular Diagnostics Market: Competitive Structure
  • Table 9: Global: Veterinary Molecular Diagnostics Market: Key Players